Your browser doesn't support javascript.
loading
Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials.
Martin-Romano, Patricia; Colmet-Daage, Leo; Morel, Daphne; Baldini, Capucine; Verlingue, Loic; Bahleda, Rastilav; Gazzah, Anas; Champiat, Stephan; Varga, Andree; Michot, Jean Marie; Ngo-Camus, Maud; Nicotra, Claudio; Marabelle, Aurelien; Soria, Jean Charles; Rouleau, Etienne; Lacroix, Ludovic; Hollebecque, Antoine; Massard, Christophe; Postel-Vinay, Sophie.
Affiliation
  • Martin-Romano P; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Colmet-Daage L; Inserm Unit U981, ATIP-Avenir Team, Villejuif, France.
  • Morel D; Inserm Unit U981, ATIP-Avenir Team, Villejuif, France.
  • Baldini C; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Verlingue L; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Bahleda R; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Gazzah A; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Champiat S; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Varga A; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Michot JM; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Ngo-Camus M; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Nicotra C; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Marabelle A; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Soria JC; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France; Inserm Unit U981, ATIP-Avenir Team, Villejuif, France.
  • Rouleau E; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Lacroix L; Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Hollebecque A; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Massard C; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France; Inserm Unit U981, ATIP-Avenir Team, Villejuif, France.
  • Postel-Vinay S; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France; Inserm Unit U981, ATIP-Avenir Team, Villejuif, France. Electronic address: Sophie.postel-vinay@gustaveroussy.fr.
Eur J Cancer ; 173: 133-145, 2022 09.
Article in En | MEDLINE | ID: mdl-35872509
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precision Medicine / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precision Medicine / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article Affiliation country: Country of publication: